Search

everythinglearnresearchcommunity

for

Search:↓

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Thyroid hormone may speed up wound healing and hair growth, but more research is needed to understand its role in skin repair and use as a treatment.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Effective treatments for severe alopecia areata are still lacking.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Finasteride does not prevent bladder cancer.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Taking a small dose of prednisone before menstruation can almost completely prevent premenstrual acne with few side effects.